Retroperitoneal fibrosis: a case of a patient (63y/o) treated with low-dose methotrexate (MTX) and 6-methylprednisolone (6-MP)
Retroperitoneal fibrosis (RPF), is a rare fibroinflammatory disease. The pathogenesis of RPF is still unclear and numerous theories have
been reported such as environmental factors, immunologic process, genetic component, local inflammation and advanced atherosclerosis.
RPF is characterized by the presence of a particular retroperitoneal fibrotic tissue which is white, woody and involving retroperitoneal
structures such as the great vessels, ureters and psoas muscle. The main complication of RPF is the obstruction of local structures such as